Browsing by Author "Madruga, José Valdez Ramalho"
Now showing items 1-8 of 8
-
Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation
Vieira, Vinicius A et al. | Date Issued: 2017 -
Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil
Hoagland, Brenda Regina de Siqueira et al. | Date Issued: 2017 -
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial
Tan, Darrell H S et al. | Date Issued: 2018 -
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
Madruga, José Valdez Ramalho et al. | Date Issued: 2007 -
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Grinsztejn, Beatriz et al. | Date Issued: 2014 -
Retenção e persistência a profilaxia pré-exposição ao HIV entre homens que fazem sexo com homens, travestis e mulheres trans: resultados de dois anos do estudo PrEP Brasil
Veloso,Valdiléa G. et al. | Date Issued: 2018A associação de emtricitabina e tenofovir para profilaxia pré-exposição (PrEP) ao HIV foi recentemente incorporada ao Sistema Único de Saúde (SUS). PrEP Brasil é um estudo demonstrativo de PrEP para homens que fazem sexo ... -
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
Grinsztejn, Beatriz et al. | Date Issued: 2018 -
Syndemics among individuals enrolled in the PrEP Brasil Study
De Boni, Raquel B. et al. | Date Issued: 2018